Novo Chairman to Step Down in Board Rift Over Pace of Change (3)

Novo Nordisk A/S Chairman Helge Lund is stepping down after a boardroom dispute over the pace of change and will be replaced by Lars Rebien Sorensen, a previous leader of the Danish drugmaker who now heads its biggest shareholder.

The move is part of a wider shakeup at the maker of Wegovy and Ozempic drugs, with more than half of the board members set to depart. It comes not long after Novo replaced its chief executive officer following a slump in the shares, as the company has fallen behind US rival Eli Lilly & Co.

Lars Rebien Sorensen

Source: Novo Nordisk Foundation

The overhaul followed ...